Σύγκριση μεθόδων

	Ερωτηματολόγιο Ποιότητας Ζωής για το Σύνδρομο Cushing (CushQoL)	AGHDA: Αξιολόγηση Ανεπάρκειας Αυξητικής Ορμόνης σε Ενήλικες
Πεδίο	Ενδοκρινολογία	Ενδοκρινολογία
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	2008	2000
Δημιουργός	Sergio Webb, María D. Bernal, Juan M. Rivera-Caravaca	Anthony Hunt, Garry Werther, Peter Wrightson
Τύπος	Patient self-report questionnaire	Patient self-report questionnaire
Θεμελιώδης πηγή	Webb, S. M., Bernal, M. D., Rivera-Caravaca, J. M., & Córdoba-Soriano, J. G. (2008). Development and validation of CushQoL, a disease-specific quality of life questionnaire in Cushing's syndrome. J Clin Endocrinol Metab, 93(5), 1751-1759.	Hunt, A. E., Werther, G. A., & Wrightson, P. (2000). The utility of AGHDA in identifying GH-deficient adults. Clin Endocrinol (Oxf), 52(3), 341-346.
Εναλλακτικές ονομασίες	Cushing QoL, CS-QoL	AGHDA-25
Συναφείς	3	3
Σύνοψη	CushQoL is a disease-specific 12-item quality of life questionnaire developed to assess the multidimensional impacts of Cushing's syndrome—a severe endocrine disorder characterized by excess cortisol production. Developed by Webb and colleagues in 2008, it captures physical symptoms (fatigue, weight gain, weakness, hirsutism), psychological manifestations (depression, anxiety, cognitive impairment), and social/occupational dysfunction unique to Cushing's syndrome. It is the standard outcome measure for assessing quality of life improvement following curative therapy.	The AGHDA is a 25-item disease-specific quality of life questionnaire designed to assess the burden of adult growth hormone (GH) deficiency. Developed by Hunt, Werther, and colleagues in 2000, it evaluates symptoms and functional impairments directly related to GH deficiency, including fatigue, reduced muscle strength, weight gain, and psychological difficulties. The instrument is widely used in endocrinology practice and clinical trials to quantify the impact of GH replacement therapy.